Latest News
2/6/2012
Biofrontera and Desitin sign marketing and distribution agreement for Ameluz® in Scandinavia
2/6/2012
Biofrontera AG: Distribution Agreement with Desitin for Ameluz® in Scandinavia
2/3/2012
Biofrontera AG – 500,000 shares subscribed in capital increase







